BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20833032)

  • 41. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Less is more when simulating unsulfated glycosaminoglycan 3D-structure: comparison of GLYCAM06/TIP3P, PM3-CARB1/TIP3P, and SCC-DFTB-D/TIP3P predictions with experiment.
    Sattelle BM; Almond A
    J Comput Chem; 2010 Dec; 31(16):2932-47. PubMed ID: 20564659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of epitopes in glycosaminoglycans immobilized on hydrophobic membranes.
    Björnsson S
    Scand J Clin Lab Invest Suppl; 2000; 233():27-35. PubMed ID: 11317939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.
    Kramer KL
    Semin Cell Dev Biol; 2010 Aug; 21(6):631-7. PubMed ID: 20599516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of chemokine-glycosaminoglycan interaction specificity.
    Kawashima H
    Methods Enzymol; 2006; 416():254-63. PubMed ID: 17113871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Free energy calculations of glycosaminoglycan-protein interactions.
    Gandhi NS; Mancera RL
    Glycobiology; 2009 Oct; 19(10):1103-15. PubMed ID: 19643843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycosaminoglycan composition changes with MG-63 osteosarcoma osteogenesis in vitro and induces human mesenchymal stem cell aggregation.
    Kumarasuriyar A; Murali S; Nurcombe V; Cool SM
    J Cell Physiol; 2009 Mar; 218(3):501-11. PubMed ID: 18988189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycosaminoglycan glycomics using mass spectrometry.
    Zaia J
    Mol Cell Proteomics; 2013 Apr; 12(4):885-92. PubMed ID: 23325770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modeling large protein-glycosaminoglycan complexes using a fragment-based approach.
    Samsonov SA; Zacharias M; Chauvot de Beauchene I
    J Comput Chem; 2019 May; 40(14):1429-1439. PubMed ID: 30768805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of human β-defensin 2 (HBD2) with glycosaminoglycans.
    Seo ES; Blaum BS; Vargues T; De Cecco M; Deakin JA; Lyon M; Barran PE; Campopiano DJ; Uhrín D
    Biochemistry; 2010 Dec; 49(49):10486-95. PubMed ID: 21062008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterisation of the glycosaminoglycan component of matrix.
    Naggi A
    Drugs Exp Clin Res; 1991; 17(1):21-5. PubMed ID: 1914832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioinformatics and molecular modelling approaches to GPCR oligomerization.
    Simpson LM; Taddese B; Wall ID; Reynolds CA
    Curr Opin Pharmacol; 2010 Feb; 10(1):30-7. PubMed ID: 20015686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra.
    Rudd TR; Skidmore MA; Guimond SE; Cosentino C; Torri G; Fernig DG; Lauder RM; Guerrini M; Yates EA
    Glycobiology; 2009 Jan; 19(1):52-67. PubMed ID: 18832453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease.
    Shi D; Sheng A; Chi L
    Front Mol Biosci; 2021; 8():639666. PubMed ID: 33768117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analytical challenges of glycosaminoglycans at biological interfaces.
    Szekeres GP; Pagel K; Heiner Z
    Anal Bioanal Chem; 2022 Jan; 414(1):85-93. PubMed ID: 34647134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the effect of VEGF glycosylation on glycosaminoglycan binding and protein unfolding.
    Brandner B; Kurkela R; Vihko P; Kungl AJ
    Biochem Biophys Res Commun; 2006 Feb; 340(3):836-9. PubMed ID: 16386708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycosaminoglycan analysis in brain stems from animals infected with the bovine spongiform encephalopathy agent.
    Papakonstantinou E; Karakiulakis G; Roth M; Verghese-Nikolakaki S; Dawson M; Papadopoulos O; Sklaviadis T
    Arch Biochem Biophys; 1999 Oct; 370(2):250-7. PubMed ID: 10510284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.
    Koopmann W; Ediriwickrema C; Krangel MS
    J Immunol; 1999 Aug; 163(4):2120-7. PubMed ID: 10438952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.